Tissue transglutaminase and celiac disease

Progress in Experimental Tumor Research

Volumn 38, Issue , 2005, Pages 158-173

  Esposito, Carla ^a   Caputo, Ivana ^a   Auricchio, Salvatore ^b   Troncone, Riccardo ^b  

^a UNIVERSITY OF SALERNO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; DIAGNOSTIC AGENT; EPITOPE; GLIADIN; GUANINE NUCLEOTIDE BINDING PROTEIN; MONOCLONAL ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TRANSGLUTAMINASE 2;

AMINO ACID SEQUENCE; AUTOIMMUNITY; BIOLOGICAL MODEL; CELIAC DISEASE; CHEMISTRY; ENZYME SPECIFICITY; ENZYMOLOGY; GENETICS; HUMAN; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; PH; REVIEW;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; AUTOANTIGENS; AUTOIMMUNITY; CELIAC DISEASE; EPITOPES; GLIADIN; GTP-BINDING PROTEINS; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINAL MUCOSA; MODELS, BIOLOGICAL; SUBSTRATE SPECIFICITY; TRANSGLUTAMINASES;

EID: 14544277082     PISSN: 00796263     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000084239     Document Type: Review

References (79)

1. Maki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, Ilonen J, Laurila K, Dahlbom I, Hansonn T, Hopfl P, Knip M: Prevalance of celiac disease among children in Finland. N Engl J Med 2003;348:2517-2524.
2. Sollid LM: Coeliac disease: Dissecting a complex inflammatory disorder. Nat Rev Immunol 2002;2:647-655.
3. Srinivasan U, Leonard N, Jones E, Kasarda DD, Weir DG, O'Farrelly C, Feighery C: Absence of oats toxicity m adult coeliac disease. BMJ 1996;313:1330-1331.
4. Lundin KE, Nilsen EM, Scott HG, Loberg EM, Gjoen A, Bratrie J, Skar V, Mendez E, Lovik A, Keit K: Oats induced villous atrophy in coeliac disease. Gut 2003;52:1649-1652.
5. Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Auricchio S, Picard J, Osman M, Quarantine S, Londei M: Association between innate response to gliadin and activation of pathogenic T cell in coeliac disease. Lancet 2003;362:30-37.
6. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E: Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 1989;169:345-350.
7. Sollid LM: Molecular basis of celiac disease. Annu Rev Immunol 2000;18:53-81.
8. Burgin-Wolff A, Gaze H, Hadziselimovic F, Huber H, Lentze MJ, Nussle D, Reymond-Berthet C: Antigliadin and antiendomysium antibody determination for celiac disease. Arch Dis Child 1990;65:909-911.
9. Dieterich W, Enhis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D: Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997;3:797-801.
10. Reif S, Lerner A: Tissue transglutaminase-the key player in celiac disease: a review. Autoimmun Rev 2004;3:40-45.
11. Collin P, Helin H, Maki M, Hallstrom O, Karvonen AL: Follow-up of patients positive in reticulin and gliadin antibody tests with normal small bowel biopsy findings. Scand J Gastroenterol 1993;28:595-598.
12. Sulkanen S, Halttunen T, Laurila K, Kolho KL, Korponay-Szabo IR, Sarnesto A, Savilahti E, Collin P, Maki M: Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998;115:1322-1328.
13. Sardy M, Odenthal U, Karpati S, Paulsson M, Smyth N: Recombinant human tissue transglutaminase ELISA for the diagnosis of gluten-sensitive enteropathy. Clin Chem 1999;45:2142-2149.
14. Sblattero D, Berti I, Trevisiol C, Marzari R, Tommasini A, Bradbury A, Fasano A, Ventura A, Not T: Human recombinant tissue transglutaminase ELISA: An innovative diagnostic assay for celiac disease. Am J Gastroenterol 2000;95:1253-1257.
15. Sblattero D, Florian F, Azzoni E, Zyla T, Park M, Baldas V, Not T, Ventura A, Marzari R, Bradbury A: The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments. Eur J Biochem 2002;269:5175-5181.
16. Nakachi K, Powell M, Swift G, Amoroso MA, Ananieva-Jordanova R, Arnold C, Sanders J, Furmaniak J, Rees Smith B: Epitopes recognised by tissue transglutaminase antibodies in coeliac disease. J Autoimmun 2004;22:53-63.
17. Meeuwisse G: Diagnostic criteria in coeliac disease. Acta Paediatr Scand 1970;59:461-463.
18. McNeish AS, Harms HK, Rey J, Shmerling DH, Visakorpi JK, Walker-Smith JA: The diagnosis of coeliac disease. A commentary on the current practices of members of the European Society for Paediatric Gastroenterology and Nutrition (ESPGAN). Arch Dis Child 1979;54:783-786.
19. Folk JE, Finlayson JS: The ε-(γ-glutamyl)lysine crosslink and the catalytic role of transglutaminases. Adv Protein Chem 1977;31:1-133.
20. Achyuthan KE, Greenberg CS: Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity. J Biol Chem 1987;262:1901-1906.
21. Hasegawa G, Suwa M, Ichikawa Y, Ohtsuka T, Kumagai S, Kikuchi M, Sato Y, Saito Y: A novel function of tissue-type transglutaminase: Protein disulphide isomerase. Biochem J 2003;373:793-803.
22. Mishra S, Murphy LJ: Tissue transglutaminase has intrinsic kinase activity: Identification of transglutaminase 2 as an insulin-like growth factor binding protein-3 kinase. J Biol Chem 2004;279:23863-23868.
23. Aeschlimann D, Thomazy V: Protein crosslinking in assembly and remodelling of extracellular matrices: The role of transglutaminases. Connect Tissue Res 2000;41:1-27.
24. Griffin M, Casadio R, Bergamini CM: Transglutaminases: Nature's biological glues. Biochem J 2002;368:377-396.
25. Lorand L, Graham RM: Transglutaminases: Crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 2003;4:140-156.
26. Lesort M, Attanavanich K, Zhang J, Johnson GV: Distinct nuclear localization and activity of tissue transglutaminase. J Biol Chem 1998;273:11991-11994.
27. Akimov SS, Krylov D, Fleischman LF, Belkin AM: Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol 2000;148:825-838.
28. Balklava Z, Verderio E, Collighan R, Gross S, Adams J, Griffin M: Analysis of tissue transglutaminase function in the migration of Swiss 3T3 fibroblasts. J Biol Chem 2002;277:16567-16575.
29. Brusco G, Muzi P, Ciccocioppo R, Biagi F, Cifone MG, Corazza GR: Transglutaminase and coeliac disease: Endomysial reactivity and small bowel expression. Clin Exp Immunol 1999;118:371-375.
30. Farrace MG, Picarelli A, Di Tola M, Sabbatella L, Marchione OP, Ippolito G, Piacentini M: Presence of anti-tissue transglutaminase antibodies in inflammatory intestinal diseases: An apoptosis-associated event? Cell Death Differ 2001;8:767-770.
31. Esposito C, Paparo F, Caputo I, Porta R, Salvati VM, Mazzarella G, Auricchio S, Troncone R: Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease. Am J Gastroenterol 2003;98:1813-1820.
32. Lu S, Saydak M, Gentile V, Stein JP, Davies PJA: Isolation and characterization of the human tissue transglutaminase gene promoter. J Biol Chem 1995;270:9748-9756.
33. Nagy L, Saydak M, Shipley N, Lu S, Basilion JP, Yan ZH, Syka P, Chandraratna RAS, Stein JP, Heyman RA, Davies PJA: Identification and characterization of a versatile retinoid response element (retinoid acid receptor response element-retinoid X receptor response element) in the mouse tissue transglutaminase gene promoter. J Biol Chem 1996;271:4355-4365.
34. Ritter SJ, Davies PJA: Identification of a transforming growth factor-β1/bone morphogenetic protein 4 (TGFβ1/BMP4) response element within the mouse tissue transglutaminase gene promoter. J Biol Chem 1998;273:12798-12806.
35. Nilsen EM; Jahnsen FL, Lundin KE, Johansen FE, Fausa O, Sollid LM, Jahnsen J, Scott H, Brandtzaeg P: Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998;115:551-563.
36. Ciccocioppo R, Di Sabatino A, Ara C, Biagi F, Perilli M, Amicosante G, Cifone MG, Corazza GR: Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa. Clin Exp Immunol 2003;134:516-524.
37. Skill NJ, Griffin M, El Nahas AM, Sanai T, Haylor JL, Fisher M, Jamie MF, Mould NN, Johnson TS: Increases in renal ε-(γ-glutamyl)-lysine crosslinks result from compartment-specific changes in tissue transglutaminase in early experimental diabetic nephropathy: Pathologic implications. Lab Invest 2001;81:705-716.
38. Gross SR, Balklava Z, Griffin M: Importance of tissue transglutaminase in repair of extracellular matrices and cell death of dermal fibroblasts after exposure to a solarium ultraviolet A source. J Invest Dermatol 2003;121:412-423.
39. Van de Wal Y, Kooy YMC, Drijfhout JW, Amons R, Koning F: Peptide binding characteristics of the coeliac disease-associated DQ (α1 *0501, β1 *0201) molecule. Immunogenetics 1996;44:246-253.
40. Sjostrom H, Lundin KEA, Molberg O, Korner R, McAdam SN, Anthonsen D, Quarsten H, Noren O, Roepstorff P, Thorsby E, Sollid LM: Identification of a gliadin T-cell epitope in coeliac disease: General importance of gliadin deamidation for intestinal T-cell recognition. Scand J Immunol 1998;48:111-115.
41. Brace SE, Bjarnason I, Peters TJ: Human jejunal transglutaminase: Demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and coelaic disease. Clin Sci 1985;68:573-579.
42. Porta R, Gentile V, Esposito C, Mariniello L, Metafora S: Cereal dietary proteins with sites for cross-linking by transglutaminase. Phytochemistry 1990;29:2801-2804.
43. Kim C-Y, Quarsten H, Bergseng E, Khosla C, Sollid LM: Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci USA 2004;101:4175-4179.
44. Molberg O, McAdam S, Lundin KEA, Kristiansen C, Arentz-Hansen H, Kett K, Sollid LM: T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase. Eur J Immunol 2001;31:1317-1323.
45. Fleckenstein B, Molberg O, Qiao SW, Schmid DG, von der Mulbe F, Elgstoen K, Jung G, Sollid LM: Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process. J Biol Chem 2002;277:34106-34116.
46. Schmidt G, Selzer J, Lerm M, Aktories K: The rho-deamidating cytotoxic necrotizing factor 1 from escherichia coli possesses transglutaminase activity: Cysteine 866 and histidine 881 are essential for enzyme activity. J Biol Chem 1998;273:13669-13674.
47. Koning F, Vader W: Gluten peptides and celiac disease. Science 2003;299:513-515.
48. Vader LW, de Ru A, van der Wal Y, Kooy YM, Benckhuijsen W, Mearin ML, Drijfhout JW, van Veelen P, Koning F: Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J Exp Med 2002;195:643-649.
49. Vader LW, Stepniak DT, Bunnik EM, Kooy YM, de Haan W, Drijfhout JW, Van Veelen PA, Koning F: Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology 2003;125:1105-1113.
50. Arentz-Hansen H, Korner R, Molberg O, Quarsten H, Vader W, Kooy YMC, Lundin KEA, Koning F, Roepstorff P, Sollid LM, McAdam SN: The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 2000;191:603-612.
51. Anderson RP, Degano P, Godkin AJ, Jewell DP, Hill AVS: In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 2000;6:337-342.
52. Arentz-Hansen H, McAdam SN, Molberg O, Fleckenstein B, Lundin KEA, Jorgensen TJD, Jung G, Roepstorff P, Sollid LM: Celiac lesion T cells recognize epitopes that cluster in regions of gliadin rich in proline residues. Gastroenterology 2002;123:803-809.
53. Shan L, Molberg O, Parrot I, Hausch F, Filiz F, Gray GM, Sollid LM, Khosla C: Structural basis for gluten intolerance in celiac sprue. Science 2002;297:2275-2279.
54. Vader W, Kooy Y, Van Veelen P, De Ru A, Harris D, Benckhuijsen W, Pena S, Mearin L, Drijthout JW, Koning F: The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 2002;122:1729-1737.
55. Molberg O, Solheim Flaete N, Jensen T, Lundin KEA, Arentz-Hansen H, Anderson OD, Uhlen AK, Sollid LM: Intestinal T-Cell responses to high-molecular-weight glutenins in celiac disease. Gastroenterology 2003;125:337-344.
56. Molberg O, McAdam S, Korner R, Quarsten H, Kristiansen C, Madsen L, Fugger L, Scott H, Noren O, Roepstorff P, Lundin KEA, Sjostrom H, Sollid LM: Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998;4:713-717.
57. Van der Wal Y, Kooy Y, van Veelen P, Pena S, Mearin L, Papadopulos G, Koning F: Cutting edge: Selective deamidation but tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 1998;161:1585-1588.
58. Marzari R, Sblattero D, Florian F, Tongiorgi E, Not T, Tommasini A, Ventura A, Bradbury A: Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease. J Immunol 2001;166:4170-4176.
59. Sollid LM, Molberg O, McAdam S, Lundin KE: Autoantibodies in celiac disease: Tissue transglutaminase-guilt by association? Gut 1997;41:851-852.
60. Schuppan D, Dieterich W, Riecken EO: Exposing gliadin as a tasty food for lymphocytes. Nat Med 1998;3:666-667.
61. Molberg O, McAdam SN, Sollid LM: Role of tissue transglutaminase in celiac disease. J Pediatr Gastroenterol Nutr 2000;30:232-240.
62. Orrù S, Caputo I, D'Amato A, Ruoppolo M, Esposito C: Proteomics identification of acyl-acceptor and acyl-donor substrates for transglutaminase in a human intestinal epithelial cell line. Implications for celiac disease. J Biol Chem 2003;278:31766-31773.
63. Clemente MG, Musu MP, Frau F, Brusco G, Sole G, Corazza GR, De Virgilis S: Immune reaction against the cytoskeleton in coeliac disease. Gut 2000;47:520-526.
64. Maki M: The humoral immune system in celiac disease. Baillieres Clin Gastroenterol 1995;9:231-249.
65. Krupickova S, Tuckova L, Flegelova Z, Michalak M, Walters JR, Whelan A, Harries J, Vencovsky J, Tlaskalova-Hogenova H: Identification of common epitopes on gliadin, enterocytes, and calreticulin recognised by antigliadin antibodies of patients with coeliac disease. Gut 1999;44:168-173.
66. Teesalu K, Uibo O, Kalkkinen N, Janmey P, Uibo R: Increased levels of IgA antibodies against desmin in children with coeliac disease. Int Arch Allergy Immunol 2001;126:157-166.
67. Stulík J, Hernychová L, Porkertová S, Pozler O, Tuckova L, Sanchez D, Bures J: Identification of new celiac disease autoantigens using proteomic analysis. Proteomics 2003;3:951-956.
68. Nemes Z, Adany R, Balas M, Boross P, Fesus L: Identification of cytoplasmic actin as an abunant glutaminyl substrate for tissue transglutaminase in HL-60 and U937 cells undergoing apoptosis. J Biol Chem 1996;272:20577-20583.
69. Madi A, Kele Z, Janaky T, Punyiczki M, Fesus L: Identification of protein substrates for transglutaminase in Caenorhabditis elegans. Biochem Biophys Res Commun 2001;283:964-968.
70. Feng JF, Readon M, Yadav SP, Im MJ: Calreticulin down-regulates both GTP binding and transglutaminase activities of transglutaminase II. Biochemistry 1999;38:10743-10749.
71. Collin P, Kaukinen K, Valimaki M, Salmi J: Endocrinological disorders and celiac disease. Endocr Rev 2002;23:464-483.
72. Caputo I, D'Amato A, Troncone R, Auricchio S, Esposito C: Translutaminase 2 in celiac disease. Amino Acids 2004;26:381-386.
73. Freitag T, Schulze-Koops H, Niedobitek G, Melino G, Schuppan D: The role of the immune response against tissue transglutaminase in the pathogenesis of coeliac disease. Autoimmun Rev 2004;3:13-20.
74. Esposito C, Paparo F, Caputo I, Rossi M, Maglio M, Sblattero D, Not T, Porta R, Auricchio S, Marzari R, Troncone R: Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ. Gut 2002;51:177-181.
75. Dieterich W, Trapp D, Esslinger B, Leidenberger M, Piper J, Hahn E, Schuppan D: Autoantibodies of patients with coeliac disease are insufficient to block tissue transglutaminase activity. Gut 2003;52:1562-1566.
76. Halttunen T, Mäki M: Serum Immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation. Gastroenterology 1999;116:566-572.
77. Korponay-Szabo IR, Halttunen T, Szalai Z, Laurila K, Kiraly R, Kovacs JB, Fesus L, Maki M: In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut 2004;53:641-648.
78. Caputo I, Barone MV, Troncone R, Auricchio S, Esposito C: Antibodies against Type 2 transglutaminase modulate actin rearrangements and cell cycle in several cell line. J Pediatr Gastroenterol Nutr 2004;39 (suppl 3):S775.
79. Hausch F, Halttunen T, Maki M, Khosla C: Design, synthesis, and evaluation of gluten peptide analogs as selective inhibitors of human tissue transglutaminase. Chem Biol 2003;10:225-231.